Author

Breelyn Wilky

University of Colorado Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew Day· 1 shared Donald Dlass· 1 shared Dong-Min Yu· 1 shared Doreen N. PalsgroveiD· 1 shared Dylan M. MarchioneiD· 1 shared E L Lee· 1 shared Eleanor M. DowelliD· 1 shared Gabriel J. StarrettiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew Day

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors

Dong-Min Yu, E L Lee, Gabriel J. Starrett, Zili Zhai, Eleanor M. Dowell, Kaitlyn Walsh, Andrew Day, Doreen N. Palsgrove, Justin Bishop, Dylan M. Marchione, Maryam Asgari, Stephen S. Chung, W.L. High, Joyce M. C. Teng, Josh Wissell, , Richard C Wang

This study identifies low-variant allele frequency IDH1/2 mutations in sporadic angiosarcoma and shows they drive tumorigenesis through non-cell-autonomous mechanisms, responding to ivosidenib treatment.

bioRxiv · May 17, 2026 · PreprintCancer Biology